HeartFlow Analysis vs AI-ECG Platform
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, highly detailed assessment of coronary artery disease (CAD) that goes beyond standard imaging. This tool is ideal for evaluating the functional significance of coronary stenoses and characterizing plaque burden using AI-powered 3D models derived from CT scans, helping to guide decisions on revascularization or further invasive testing.
View HeartFlow Analysis →Choose AI-ECG Platform if…
Choose the AI-ECG Platform if you need rapid, AI-powered interpretation of 12-lead resting ECGs for a broad spectrum of cardiovascular conditions. This platform is best suited for scenarios demanding quick and accurate identification of arrhythmias, myocardial ischemia, or hypertrophy, providing immediate diagnostic assistance in emergency departments, primary care, or cardiology practices.
View AI-ECG Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | AI-ECG Platform |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS) | Workstation (with GPU), web-based portal, Windows-based diagnostic client |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-ECG PlatformThe AI-ECG Platform (Tool B) offers more flexible deployment options, including a workstation client, web-based portal, and Windows client, making it adaptable to various clinical environments. Its hardware independence allows compatibility with most existing ECG machines, and its rapid 3-second diagnosis enhances workflow efficiency.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis (Tool A) provides a more advanced and comprehensive non-invasive assessment of coronary artery disease, including personalized 3D models, functional FFRct analysis, and plaque characterization. This offers deeper insights that can directly impact treatment decisions and potentially reduce the need for invasive procedures.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis (Tool A) has a significant advantage with established Category I CPT codes (75580, 75577 for 2026) and widespread coverage by Medicare and most U.S. commercial payers. This provides a clear reimbursement pathway, making it a more financially viable option for healthcare providers.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis (Tool A) explicitly states HIPAA compliance and the availability of Business Associate Agreements (BAAs), which are critical for enterprise adoption. Its cloud-based deployment on AWS also offers robust scalability and security, further enhancing its readiness for large healthcare systems.
Innovation
HeartFlow AnalysisHeartFlow Analysis (Tool A) represents a more significant innovation by pioneering the use of AI and computational fluid dynamics to derive functional FFRct from standard CT scans. This offers a unique non-invasive diagnostic pathway for complex coronary artery disease, moving beyond traditional anatomical assessment.
Support & Docs
HeartFlow AnalysisHeartFlow Analysis (Tool A) appears to offer more comprehensive support, including clinical specialists and a wider range of educational resources beyond standard product documentation. This level of support is crucial for the effective implementation and utilization of a complex diagnostic tool.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | AI-ECG Platform |
|---|---|---|
| Description | HeartFlow Analysis is a commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy. |
| Company | HeartFlow | Shenzhen Carewell Electronics Co., Ltd. |
| Tagline | Decisive Coronary Care | AI-Powered Analysis System for ECG |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmap™ Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | AI-powered automatic ECG analysis and diagnosis, Over 95% accuracy in diagnosing major cardiovascular diseases, Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, Hardware independent, compatible with most ECG machines, Web-based Management Portal for organization settings, security, and task management, AI-ECG Diagnostic Client for professional ECG review, waveform measurement, and report generation, Rapid diagnosis in approximately 3 seconds, Supports various ECG data formats: Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and AI-ECG Platform.